Image via Wikipedia
Scientists in Melbourne for the first time have created a human stem cell reserve in Australia using a technique that avoids destroying embryos, which was developed in Japan and the United States.
The team from the Monash medical research institute produced an induced pluripotent stem cell line (IpS) that acts like embryonic stem cells, but are derived from adult skin cells. The method used to reprogram adult stem cells developed last year in Japan and the United States allows for the production of IpSs, which are used to study degenerative diseases like Parkinson’s without having to deal
A new biomaterial that enhances the ability of stem cells to regenerate into nerves and body parts has been developed by Australian and British scientists.
The work was a result of a joint study undertaken by the researchers at the Melbourne-based Monash University and UK-based University of Warwick.
Other biomedical “scaffold” materials, which act as templates for tissue regeneration, already exist but they cannot communicate effectively with the cells they are trying to influence.
The researchers have created a more advanced material that targets specific cells and provides clear signals to these cells to enhance regeneration.
Warnings are being issued by experts of the dangers of medical tourism saying that unproven stem cell therapy overseas could leave patients worse off.
Signing up for stem cell therapy is worth the risk for many people who are suffering with conditions like spinal injury, multiple sclerosis, motor neuron or Parkinson’s disease.
A medical journal reported earlier this year that an Israeli teenager developed brain tumors after experimental injections at a Russian clinic.
There are alternate reports also of patients contracting meningitis after treatments in China.
A handbook will be released by the Australian Stem Cell Centre to help patients analyze radial stem
Oregon Health & Science University’s unique method of transforming a person’s own skin cells into stem cells has officially been patented. The United States Patent and Trademark Office, an agency within the U.S. Department of Commerce, issued the patent earlier this year. Securing a patent is a key step in commercializing discoveries, an important objective for OHSU. Revenue from commercialized discoveries has the potential to bring financial benefit to the university and the state of Oregon.
The procedure, developed by Shoukhrat Mitalipov, Ph.D. at OHSU’s Oregon National Primate Research Center, accelerated efforts to generate stem cell therapies for humans. The
It may seem surprising, but more than 1,700 dogs in the USA with arthritis have already been treated with their own stem cells.
Remember the saying “Patient Heal Thyself?” We all — human and animals — carry around a stem cell repair kit that is used every day in helping heal the minor bumps, bruises, cuts and more serious injuries.
These stem cells are called “adult” stem cells and are found throughout the body. They sit there waiting for the signal that they are needed and they rush to the scene of the injury and begin the healing process.
So we really